Dr. Timothy C. Kasunic, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Wayne State University School of Medicine (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 809
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: Wayne State University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
OH license 35.087790CTR · MI license 4301076035
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Promedica Toledo Hospital Toledo, OH
- Mercy St Vincent Medical Center Toledo, OH
- Promedica Monroe Regional Hospital Monroe, MI
- University of Toledo Medical Center Toledo, OH
- Fulton County Health Center Wauseon, OH
Medical groups
- Toledo Clinic Incorporated (210 clinicians)
- Fchc Medical Care, LLC (59 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 809
- Services billed
- 319,353
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, ferric carboxymaltose, 1 mg | 72,750 | 67 |
| Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 37,200 | 13 |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | 13,680 | 15 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 13,260 | 16 |
| Injection, pembrolizumab, 1 mg | 11,800 | 13 |
| Injection, nivolumab, 1 mg | 9,580 | 11 |
| Injection, denosumab, 1 mg | 7,860 | 59 |
| Injection, aprepitant, 1 mg | 7,670 | 19 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,030 | 29 |
| Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 4,952 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Toledo, OH | 245 |
| Prednisone Other prescribers in Toledo, OH | 162 |
| Acyclovir Other prescribers in Toledo, OH | 161 |
| Abiraterone Acetate | 120 |
| Prochlorperazine Maleate Other prescribers in Toledo, OH | 117 |
| Eliquis (apixaban) Other prescribers in Toledo, OH | 111 |
| Venclexta (venetoclax) | 100 |
| Ibrance (palbociclib) | 93 |
| Letrozole Other prescribers in Toledo, OH | 76 |
| Dexamethasone Other prescribers in Toledo, OH | 60 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 6 payments worth $226 in total to this clinician.
| Janssen Biotech, Inc. | $99.99 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $34.24 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.89 |
| Adc Therapeutics America, Inc. | $20.79 |
| Aveo Pharmaceuticals, Inc. | $20.00 |
| Astellas Pharma US Inc | $19.94 |
| Education | $120 |
|---|---|
| Food and Beverage | $106 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Dec 9, 2025 | Education ERLEADA · Oncology · in-kind | $99.99 |
| Aveo Pharmaceuticals, Inc. Feb 13, 2025 | Education FOTIVDA · Oncology · in-kind | $20.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.